top of page

family on a walk hero image 3.jpg

News & Events

May 2, 2024

RS Oncology Data for Novel Treatment of Aggressive Cancers Selected for an Oral Presentation at ASCO Annual Meeting

March 30, 2024

RS Oncology to present translational data identifying potential biomarkers associated with RSO-021 anticancer activity

March 5, 2024

Recent advancements in treating malignant pleural mesothelioma and why localized treatment could be advantageous

February 2, 2024

RS Oncology Announces First Patient Dosed in Phase 2 Clinical Study (MITOPE) Investigating RSO-021 for the Treatment of Malignant Pleural Mesothelioma and Metastatic Disease to the Lung

rso footer.jpg

bottom of page